Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
19 nov. 2024 09h00 HE
|
Qualigen Therapeutics, Inc.
Carlsbad, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), Qualigen Therapeutics, Inc., is a life science company focused on developing...